For decades, glycogen in the brain was thought to act like a spare battery - a short-term fuel released only during crisis, such as hypoglycemia or oxygen deprivation. But scientists at the University of Trento have uncovered a deeper function. Glycogen, they report, is not only an energy buffer; it is a metabolic separator, keeping two of the brain's most demanding processes from colliding.
A dual-purpose molecule
Inside astrocytes - the supportive glial cells that wrap around neurons - glycogen stores both glucose and a surprising additive: glucosamine, which makes up nearly one-quarter of its structure. When broken down, this glucosamine supports protein glycosylation - the process of decorating proteins with sugar chains that determine their stability, folding, and signaling roles at the synapse.
At first glance, this may seem unrelated to neural firing. But the chemistry intertwines: the same biochemical pathway that produces glucosamine also consumes glutamine, the raw material for building glutamate and GABA, the neurotransmitters that balance brain excitation and inhibition.
Without a steady glycogen-derived supply of glucosamine, the brain would have to divert glutamine away from neurotransmission toward protein modification - a trade-off that risks depleting inhibitory control and triggering seizures.
Trentini and colleagues propose that by storing glucosamine within glycogen, astrocytes keep these systems safely apart. Glycogen thus acts like a biochemical firewall - providing glycosylation material without stealing from the neurotransmitter pool.
The astrocyte-neuron partnership
Astrocytes have long been known to feed neurons through the astrocyte - neuron lactate shuttle, supplying lactate as a quick energy source during bursts of activity. But their glycogen now appears to coordinate a second kind of support: molecular supply-chain management.
When neurons fire rapidly, astrocytic glycogen is mobilized to provide glucose, lactate, and glucosamine in balanced amounts. Once activity subsides, glycogen is replenished - this time using glucose from the blood and new glucosamine synthesized from fructose-6-phosphate and glutamine. A feedback system involving the enzyme GFAT ensures that if glycogen breakdown is active, glucosamine synthesis slows, preventing waste and preserving neurotransmitter balance.
If this coordination fails - through genetic mutations or metabolic stress - the consequences ripple through the brain's communication network. The result is not just energy shortage, but mis-timed neurotransmission and impaired protein folding at the synapse.
When separation fails: seizures and degeneration
The study draws connections between neurological glycogen storage diseases (GSDs) and congenital disorders of glycosylation (CDGs) - two families of rare conditions that, surprisingly, share similar symptoms: developmental delay, cognitive decline, and epilepsy.
In both cases, neurons and astrocytes lose their ability to manage glycogen's dual role. In disorders like Lafora disease, defective glycogen breakdown leads to insoluble glycogen aggregates (Lafora bodies) that trap glucose and glucosamine. The resulting shortage disrupts both glycosylation and neurotransmitter recycling - producing the characteristic, drug-resistant seizures seen in adolescence.
Other GSDs, such as GLUT1 deficiency or GYS1 mutations, similarly interfere with glycogen's regulation, leading to energy deficits, glutamine imbalance, and abnormal excitation in cortical and thalamic circuits. In these diseases, the line between energy metabolism and neurotransmission blurs - precisely what brain glycogen evolved to prevent.
The metabolic mirror: when different diseases overlap
The authors point out that glycogen storage diseases and glycosylation disorders are not isolated. They form a metabolic continuum, linked through shared pathways involving glycolysis, neurotransmitter cycles, and protein folding. This overlap suggests that treatments developed for one group of diseases may benefit the other.
For instance, ketogenic diets - used to stabilize seizures in GLUT1 deficiency - also support energy metabolism in Lafora disease. Similarly, supplementing specific sugars (mannose, galactose, or fucose) can restore protein glycosylation in congenital glycosylation disorders and might help counteract defects in glycogen-related epilepsy.
This cross-therapeutic potential highlights a deeper principle: in the brain, metabolism and information are inseparable. Energy, structure, and communication share the same chemical language.
Why it matters beyond rare diseases
The research extends beyond pathology. It proposes that the same fragile balance between energy storage, neurotransmission, and glycosylation might slowly drift with aging. Subtle glycogen mismanagement in astrocytes could contribute to declining cognitive function, increased oxidative stress, and vulnerability to neurodegenerative diseases such as Alzheimer's and Parkinson's.
The study invites a re-examination of how "support cells" orchestrate higher cognition - not by electrical signaling but by chemical timing. Astrocytes, through glycogen's complex chemistry, may serve as the unseen moderators of consciousness itself, keeping the brain's design and its dialogue in harmony.
